Osteosarcoma: Diagnosis, Treatment, and Emerging Opportunities

Area of Science:

• Pediatric Oncology
• Skeletal Malignancies
• Cancer Therapeutics

Background:

• Osteosarcoma is the most frequent primary bone cancer in children and adolescents.
• Treatment efficacy for osteosarcoma has remained largely unchanged for approximately 40 years.
• Current treatment protocols do not significantly differentiate between standard and high-risk disease.

Purpose of the Study:

• To review the current landscape of osteosarcoma treatment.
• To highlight recent advancements in therapeutic strategies for osteosarcoma.
• To identify promising novel approaches for osteosarcoma management.

Main Methods:

• Literature review of recent studies on osteosarcoma treatment.
• Analysis of evidence for multitargeted tyrosine kinase inhibitors in advanced osteosarcoma.
• Exploration of novel therapeutic targets, including cell surface antigens and DNA repair pathways.

Main Results:

• Multitargeted tyrosine kinase inhibitors show activity in advanced osteosarcoma.
• Further investigation is warranted for the use of these inhibitors in newly diagnosed patients.
• Novel strategies are being developed to target specific cell surface antigens (LRRC15, B7-H3) and aberrant molecular pathways.

Conclusions:

• Outcomes for osteosarcoma remain a significant challenge in pediatric oncology.
• Targeted therapies, including tyrosine kinase inhibitors, represent a promising avenue for treatment advancement.
• Exploiting specific molecular targets offers potential for developing more effective and personalized osteosarcoma therapies.